5 COVID-19 Clinical Trials in Bethesda, MD (2026)

Q: How do I join a clinical trial in Bethesda?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Bethesda research site will contact you.

Recruiting COVID-19 Studies in Bethesda

NCT04573062Recruiting

Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health

Background: People who get COVID-19 have a wide range of symptoms. They also recover from COVID-19 in different ways. In this study, researchers will use survey data to describe the different ways pe...

Bethesda, MD1,590 participantsNational Institute of Neurological Disorders and Stroke (NINDS)

View Study Details

NCT05078905Recruiting

Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases

Background: Vaccines against SARS-CoV-2, the virus that causes COVID-19, have been highly effective against preventing severe disease. But the protective effects of these vaccines appear to wane over...

Bethesda, MD1,200 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT06441955Recruiting

Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.

Investigators are conducting a study on alternative treatments for patients who have received an current or previous positive COVID-19 diagnosis with mild-serve symptoms or undiagnosable condition aft...

Bethesda, MD100 participantsWell- Konnect Healthcare Services and Research Firm

View Study Details

NCT06920628Recruiting

PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

Background: SARS-CoV-2 is the virus that causes COVID-19. Some people who recover from COVID-19 have long-term symptoms that affect the brain. These include headaches; loss of taste and smell; sleep ...

Bethesda, MD60 participantsNational Institute of Mental Health (NIMH)

View Study Details

NCT06577467Recruiting

Cross-Sectional Evaluation of Persistence of SARS-CoV-2 Remnants After Recovery From Acute Infection

Background: SARS-CoV-2 is the virus that causes COVID-19. Some people who recover from COVID-19 have symptoms that last long after the active infection ends. This is called long COVID. Sometimes, lon...

Bethesda, MD12 participantsNational Institute of Neurological Disorders and Stroke (NINDS)

View Study Details

About COVID-19 Clinical Trials in Bethesda

COVID-19 is an infectious disease caused by the SARS-CoV-2 virus that primarily affects the respiratory system. Long COVID (PASC) involves persistent symptoms weeks or months after initial infection. Treatment includes antiviral medications, monoclonal antibodies, and supportive care.

There are currently 5 covid-19 clinical trials recruiting participants in Bethesda, MD. These studies are seeking a combined 2,962 participants. Research is being sponsored by National Institute of Neurological Disorders and Stroke (NINDS), National Institute of Allergy and Infectious Diseases (NIAID), Well- Konnect Healthcare Services and Research Firm and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

COVID-19 Clinical Trials in Bethesda — FAQ

Are there covid-19 clinical trials in Bethesda?

Yes, there are 5 covid-19 clinical trials currently recruiting in Bethesda, MD. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Bethesda?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bethesda research site will contact you about next steps.

Are clinical trials in Bethesda free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bethesda studies also compensate for your time and travel.

What covid-19 treatments are being tested?

The 5 active trials in Bethesda are testing new therapies including novel drugs, biologics, and treatment approaches for covid-19.

Data updated July 13, 2026 from ClinicalTrials.gov